vaccines

News

COVID-19 vaccinations now ‘alarmingly low’ in Europe

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

R&D

Group of people in lab where Quillaja saponaria trees grow

Plants and vaccine adjuvants: BSI’s sustainable trees in a l...

This time last year, Croda Pharma and Botanical Solution Inc (BSI) announced that they’d entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutic

News

Novavax investor withdraws proxy fight after Sanofi deal

Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the wake of its $1.2 billion alliance with Sanofi.

R&D

Overcoming challenges with maternal vaccine trials

Childhood vaccines have proven to be one of the most effective public health interventions to reduce infant and child mortality.

News

FDA delays decision on Moderna’s RSV vaccine

Moderna’s first attempt to expand its commercial activities beyond COVID-19 vaccines, its respiratory syncytial virus (RSV) shot, has suffered a delay in the US.

News

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up

COVID-19 vaccinations now ‘alarmingly low’ in Europe

Plants and vaccine adjuvants: BSI’s sustainable trees in a l...

Novavax investor withdraws proxy fight after Sanofi deal

Overcoming challenges with maternal vaccine trials

FDA delays decision on Moderna’s RSV vaccine

Sanofi forges $1.2bn alliance with vaccines firm Novavax

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

vaccines

Editor's Picks